ViroCell Biologics

ViroCell Biologics is a leading innovation-driven Contract Development and Manufacturing Organization (CDMO) specializing in biotechnology research. ViroCell Biologics is dedicated to powering innovation on the journey from lab to life, manufacturing viral vectors and gene-modified cells. These enable novel cell and gene therapies to enter clinical trials, bringing cutting-edge medical advancements closer to patients. The primary address for ViroCell Biologics is in London, GB.

ViroCell Biologics plays a pivotal role in advancing the biotechnology industry. By focusing on viral vector and gene-modified cell manufacturing, ViroCell Biologics supports the development of groundbreaking treatments and therapies. ViroCell Biologics is committed to maintaining the highest standards of quality and precision in its manufacturing processes, ensuring that its partners receive reliable and effective products.

With its dedication to innovation and its critical role in the development of novel therapies, ViroCell Biologics is well-positioned to drive progress in the field of biotechnology research. We invite the manager of ViroCell Biologics to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional offerings.